Avenzo Therapeutics, Inc. ("Avenzo"), a clinical-stage biotechnology company developing next-generation oncology therapies, today reported initial clinical data from the Phase 1 portion of its ongoing ...
Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces today positive topline results in its 13-week Phase II study evaluating ASC30, an oral small molecule GLP-1 receptor (GLP-1R) agonist for the ...
Detailed price information for Jupiter Neurosciences Inc (JUNS-Q) from The Globe and Mail including charting and trades.
Pfizer Inc. (NYSE: PFE) today announced detailed results from the Phase 3 HER2CLIMB-05 trial of the tyrosine kinase inhibitor ...
Elana Thieme and Mark Mendoza, fourth-year graduate students in the Molecular and Cell Biology (MCB) PhD Program jointly ...
From 11.5 million alloy candidates to AI-guided perovskites, this piece unpacks how materials informatics is speeding up ...
Morning Overview on MSN
AI now decodes sweat to spot early signs of disease
Sweat is turning into one of medicine’s most revealing data streams, and artificial intelligence is learning how to read it.
Evercore 8th Annual Healthcare Conference December 3, 2025 10:50 AM ESTCompany ParticipantsDietmar Berger - Chief ...
Good day, and thank you for joining us. Yesterday, we issued a press release relating to the Phase III HARMONi-6 data ...
Serious side effects, including neurotoxicity and intestinal inflammation, that appear weeks or months after patients receive ...
Zentalis has taken a beating in 2025 to date, as the market continues to value their pipeline as a liability rather than an ...
Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced the first patient has been dosed in the Phase 1/2 study evaluating CRN09682 in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback